Tag:
off-label
Latest Headlines
Latest Headlines
Hospitals should cut down off-label use of hemophilia drug
Researchers caution against off-label prescribing of the $10,000-per-dose hemophilia medication NovoSeven. Their reasoning: It rarely saves lives and may actually cause clotting problems and strokes
